Skip to main content

AEON Biopharma, Inc.

AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001837607

In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.

Superinvestors holding AEON, Q2 2026

See all superinvestors

No superinvestor reported holding AEON in Q2 2026.